KYTX · Kyverna Therapeutics, Inc.
Market Cap
$517.63M
Shares
61.84M
Kyverna Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Kyverna Therapeutics, Inc. (KYTX), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Conference
Investor event
2026-06-03
Kyverna Therapeutics, Inc. (KYTX) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-12
Kyverna Therapeutics, Inc. (KYTX) Q1 2026 Earnings Call
Diluted EPS
$-0.66
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-04-22
Kyverna Therapeutics, Inc. (KYTX) April 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2026-01-12
Kyverna Therapeutics, Inc. (KYTX) Q4 2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q2
2025-08-28
Kyverna Therapeutics, Inc. (KYTX) Q2 2025 Earnings Call
Diluted EPS
$-0.97
Audio
Transcript
Slides
8-K10-Q
Showing 1–5 of 5 earnings calls
Key facts
CIK
1994702
CUSIP
501976104
13F (30d)
100 filings
100 filers
Visit website
Investor relations